Gokhan Yahioglu
Fondateur chez Antikor Biopharma Ltd.
Profil
Gokhan Yahioglu is the founder of Antikor Biopharma Ltd.
which was founded in 2001, where he holds the title of Technical Director.
Currently, he is a Principal at Imperial College London since 1997.
In the past, he worked as a Principal at the University of Cambridge.
Dr. Yahioglu received a doctorate degree from Brunel University.
Postes actifs de Gokhan Yahioglu
| Sociétés | Poste | Début |
|---|---|---|
Antikor Biopharma Ltd.
 Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Fondateur | 01/03/2001 |
| Imperial College London | Corporate Officer/Principal | 01/01/1997 |
Anciens postes connus de Gokhan Yahioglu
| Sociétés | Poste | Fin |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Formation de Gokhan Yahioglu
| Brunel University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Health Technology |
